Genfit Financials

GNFT Stock  USD 3.64  0.13  3.70%   
Based on the key indicators related to Genfit's liquidity, profitability, solvency, and operating efficiency, Genfit may be sliding down financialy. It has an above-average odds of going through some form of financial crisis next quarter. At this time, Genfit's Other Current Assets are comparatively stable compared to the past year. Other Stockholder Equity is likely to gain to about 536.5 M in 2025, whereas Total Current Liabilities is likely to drop slightly above 24.2 M in 2025. Key indicators impacting Genfit's financial strength include:
Current ValueLast YearChange From Last Year 10 Year Trend
Current Ratio3.512.65
Significantly Up
Very volatile
The financial analysis of Genfit is a critical element in measuring its lifeblood. Investors should not minimize Genfit's ability to pay suppliers or employees on time, ensuring interest payments are not accumulating.

Net Income

(27.3 Million)

  
Understanding current and past Genfit Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Genfit's financial statements are interrelated, with each one affecting the others. For example, an increase in Genfit's assets may result in an increase in income on the income statement.
Please note, the imprecision that can be found in Genfit's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Genfit. Check Genfit's Beneish M Score to see the likelihood of Genfit's management manipulating its earnings.

Genfit Stock Summary

Genfit competes with HCW Biologics, Molecular Partners, MediciNova, Anebulo Pharmaceuticals, and Champions Oncology. Genfit S.A., a biopharmaceutical company, discovers and develops drug candidates and diagnostic solutions for metabolic and liver-related diseases. Genfit S.A. was incorporated in 1999 and is headquartered in Loos, France. Genfit SA operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 134 people.
Specialization
Health Care, Pharmaceuticals, Biotechnology & Life Sciences
InstrumentUSA Stock View All
ExchangeNASDAQ Exchange
ISINUS3722791098
CUSIP372279109
LocationFrance
Business AddressParc EurasantE, Loos,
SectorBiotechnology
IndustryHealth Care
BenchmarkDow Jones Industrial
Websitewww.genfit.com
Phone33 3 20 16 40 00
CurrencyUSD - US Dollar

Genfit Key Financial Ratios

Genfit Key Balance Sheet Accounts

202020212022202320242025 (projected)
Total Assets198.6M281.7M215.5M173.9M200.0M135.4M
Other Current Liab5.6M29.0M6.3M20.1M23.1M24.3M
Net Debt14.7M(184.5M)(60.7M)(7.6M)(6.8M)(7.2M)
Retained Earnings(404.9M)(337.8M)(361.3M)(389.8M)(350.8M)(333.3M)
Accounts Payable20.3M12.3M8.6M10.4M12.0M12.0M
Cash171.0M258.8M136.0M77.8M89.5M105.9M
Net Receivables11.9M7.2M15.9M18.5M21.3M22.4M
Other Current Assets1.8M2.1M2.0M16.8M15.1M15.9M
Total Liab214.8M162.6M121.0M105.9M121.8M84.4M
Total Current Assets184.7M268.1M158.5M113.1M130.1M117.4M
Short Term Debt4.3M2.2M5.1M7.9M9.1M9.6M
Intangible Assets791K174K44.0M48.8M56.1M58.9M
Common Stock9.7M9.7M12.5M12.5M14.3M15.0M
Other Assets1K1.5M4.4M1.3M(1.2K)(1.1K)
Other Liab2.9M3.1M2.4M27.7M31.9M33.5M
Net Tangible Assets20.1M83.1M(17.0M)118.9M107.0M57.5M
Long Term Debt181.3M72.0M70.2M57.4M66.1M108.0M
Short Long Term Debt4.3M2.2M5.1M6.9M7.9M8.3M
Net Invested Capital169.5M193.3M169.8M132.2M119.0M157.1M

Genfit Key Income Statement Accounts

The reason investors look at the income statement is to determine what Genfit's earnings per share (EPS) will be in order to see if they want to buy more shares or not. For example, if a company earned $20 million in the last quarter and has 100,000 shares outstanding, its EPS is 20 cents. If you find that this number beats analysts' forecasts or is higher than it was from the same period last year, then you might want to buy more of this stock even though its price per share may not have changed.
202020212022202320242025 (projected)
Interest Expense25.3M7.1M4.8M4.6M5.3M4.1M
Total Revenue765K80.1M20.2M28.6M32.8M34.5M
Gross Profit563K79.9M19.9M28.2M32.5M34.1M
Operating Income(77.8M)76.7M(27.5M)(26.6M)(23.9M)(25.1M)
Ebit(95.9M)32.2M(25.4M)(23.9M)(21.5M)(22.6M)
Ebitda(91.1M)34.9M(23.6M)(22.2M)(20.0M)(21.0M)
Income Before Tax(101.6M)69.5M(23.8M)(28.5M)(25.7M)(26.9M)
Net Income(101.2M)67.3M(23.7M)(28.9M)(26.0M)(27.3M)
Income Tax Expense(428K)2.2M(116K)380K437K458.9K
Research Development59.1M35.2M35.8M46.7M53.7M34.4M
Tax Provision(428K)2.2M(116K)380K437K458.9K
Net Interest Income(18.8M)37.7M3.5M(1.4M)(1.6M)(1.6M)
Interest Income6.5M44.8M8.2M1.7M2.0M1.9M

Genfit Key Cash Accounts

202020212022202320242025 (projected)
Change In Cash(105.7M)87.7M(122.8M)(58.2M)(52.4M)(49.8M)
Free Cash Flow(97.3M)99.4M(72.6M)(57.9M)(52.1M)(49.5M)
Depreciation3.6M2.7M1.8M1.7M1.9M1.6M
Other Non Cash Items11.6M(32.5M)3.9M(1.3M)(1.2M)(1.1M)
Capital Expenditures900K537K0.02.5M2.9M3.0M
Net Income(101.2M)67.3M(23.7M)(28.9M)(26.0M)(27.3M)
End Period Cash Flow171.0M258.8M136.0M77.8M89.5M105.6M
Investments(66K)(3.4M)(46.3M)2.2M2.0M2.1M
Net Borrowings(200K)(1.9M)(1.9M)(35.1M)(31.5M)(30.0M)
Change To Netincome11.3M14.6M12.4M(29.8M)(26.8M)(25.4M)

Genfit Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Genfit's current stock value. Our valuation model uses many indicators to compare Genfit value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Genfit competition to find correlations between indicators driving Genfit's intrinsic value. More Info.
Genfit is one of the top stocks in return on equity category among its peers. It is rated # 2 in return on asset category among its peers reporting about  0.25  of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Genfit is roughly  3.98 . At this time, Genfit's Return On Equity is comparatively stable compared to the past year. Comparative valuation analysis is a catch-all technique that is used if you cannot value Genfit by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.

Genfit Systematic Risk

Genfit's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Genfit volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was one with a total number of output elements of sixty. The Beta measures systematic risk based on how returns on Genfit correlated with the market. If Beta is less than 0 Genfit generally moves in the opposite direction as compared to the market. If Genfit Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Genfit is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Genfit is generally in the same direction as the market. If Beta > 1 Genfit moves generally in the same direction as, but more than the movement of the benchmark.

Genfit Thematic Clasifications

Genfit is part of several thematic ideas from Health Management to Management. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. Get More Thematic Ideas
Today, most investors in Genfit Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Genfit's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Genfit growth as a starting point in their analysis.

Price Earnings To Growth Ratio

(0.28)

At this time, Genfit's Price Earnings To Growth Ratio is comparatively stable compared to the past year.

Genfit March 17, 2025 Opportunity Range

Along with financial statement analysis, the daily predictive indicators of Genfit help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Genfit. We use our internally-developed statistical techniques to arrive at the intrinsic value of Genfit based on widely used predictive technical indicators. In general, we focus on analyzing Genfit Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Genfit's daily price indicators and compare them against related drivers.

Additional Tools for Genfit Stock Analysis

When running Genfit's price analysis, check to measure Genfit's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Genfit is operating at the current time. Most of Genfit's value examination focuses on studying past and present price action to predict the probability of Genfit's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Genfit's price. Additionally, you may evaluate how the addition of Genfit to your portfolios can decrease your overall portfolio volatility.